Next Article in Journal
Expression Characteristics and Prognostic Value of KLRG2 in Endometrial Cancer: A Comprehensive Analysis Based on Multi-Omics Data
Previous Article in Journal
Applications of CRISPR-Cas-Based Genome Editing Approaches Against Human Cytomegalovirus Infection
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Paucarmayta et al. Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro. Biomedicines 2020, 8, 73

1
Department of Obstetrics & Gynecology, Uniformed Services University, 4301 Jones Bridge Road, Bethesda, MD 20814, USA
2
Gynecologic Cancer Center of Excellence, Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, 8901 Wisconsin Avenue, Bethesda, MD 20889, USA
3
John P. Murtha Cancer Center, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, 8901 Wisconsin Avenue, Bethesda, MD 20889, USA
4
Gynecologic Cancer Center of Excellence, Women’s Health Integrated Research Center at Inova Health System, 3289 Woodburn Road, Suite 370, Annandale, VA 22003, USA
5
Inova Fairfax Hospital, Department of Obstetrics & Gynecology, 3300 Gallows Road, Falls Church, VA 22042, USA
6
Department of Molecular and Cell Biology, Uniformed Services University, 4301 Jones Bridge Road, Bethesda, MD 20814, USA
*
Author to whom correspondence should be addressed.
Biomedicines 2025, 13(7), 1591; https://doi.org/10.3390/biomedicines13071591
Submission received: 12 March 2025 / Accepted: 18 June 2025 / Published: 30 June 2025
(This article belongs to the Section Cancer Biology and Oncology)

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The journal retracts the article, “Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro” [...]

Share and Cite

MDPI and ACS Style

Paucarmayta, A.; Taitz, H.; McGlorthan, L.; Casablanca, Y.; Maxwell, G.L.; Darcy, K.M.; Syed, V. RETRACTED: Paucarmayta et al. Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro. Biomedicines 2020, 8, 73. Biomedicines 2025, 13, 1591. https://doi.org/10.3390/biomedicines13071591

AMA Style

Paucarmayta A, Taitz H, McGlorthan L, Casablanca Y, Maxwell GL, Darcy KM, Syed V. RETRACTED: Paucarmayta et al. Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro. Biomedicines 2020, 8, 73. Biomedicines. 2025; 13(7):1591. https://doi.org/10.3390/biomedicines13071591

Chicago/Turabian Style

Paucarmayta, Ana, Hannah Taitz, Latoya McGlorthan, Yovanni Casablanca, G. Larry Maxwell, Kathleen M. Darcy, and Viqar Syed. 2025. "RETRACTED: Paucarmayta et al. Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro. Biomedicines 2020, 8, 73" Biomedicines 13, no. 7: 1591. https://doi.org/10.3390/biomedicines13071591

APA Style

Paucarmayta, A., Taitz, H., McGlorthan, L., Casablanca, Y., Maxwell, G. L., Darcy, K. M., & Syed, V. (2025). RETRACTED: Paucarmayta et al. Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro. Biomedicines 2020, 8, 73. Biomedicines, 13(7), 1591. https://doi.org/10.3390/biomedicines13071591

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop